Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.
Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Troland D, MacPherson I, Graham C, Aird R, Semple SIK, Morris DM, Fraser AR, Pass C, McGowan NWA, Turner ML, Manson L, Lachlan NJ, Dillon JF, Kilpatrick AM, Campbell JDM, Fallowfield JA, Forbes SJ. Brennan PN, et al. Among authors: pass c. Nat Med. 2025 Jan 10. doi: 10.1038/s41591-024-03406-8. Online ahead of print. Nat Med. 2025. PMID: 39794616
Quantifying and reducing the cost of tagging: combining computational fluid dynamics and diving experiments to reduce impact from animal-borne tags.
McKnight JC, Pass C, Thompson D, Balfour S, Brasseur SMJM, Embling C, Hastie G, Milne R, Kyte A, Moss SEW, Pemberton R, Russell DJF. McKnight JC, et al. Among authors: pass c. Proc Biol Sci. 2024 Nov;291(2034):20241441. doi: 10.1098/rspb.2024.1441. Epub 2024 Nov 6. Proc Biol Sci. 2024. PMID: 39501884 Free PMC article.
Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease.
Balestrieri N, Palzkill V, Pass C, Tan J, Salyers ZR, Moparthy C, Murillo A, Kim K, Thome T, Yang Q, O'Malley KA, Berceli SA, Yue F, Scali ST, Ferreira LF, Ryan TE. Balestrieri N, et al. Among authors: pass c. Circ Res. 2023 Jul 7;133(2):158-176. doi: 10.1161/CIRCRESAHA.123.322875. Epub 2023 Jun 16. Circ Res. 2023. PMID: 37325935 Free PMC article.
Chronic activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney disease.
Balestrieri N, Palzkill V, Pass C, Tan J, Salyers ZR, Moparthy C, Murillo A, Kim K, Thome T, Yang Q, O'Malley KA, Berceli SA, Yue F, Scali ST, Ferreira LF, Ryan TE. Balestrieri N, et al. Among authors: pass c. bioRxiv [Preprint]. 2023 May 18:2023.05.16.541060. doi: 10.1101/2023.05.16.541060. bioRxiv. 2023. Update in: Circ Res. 2023 Jul 7;133(2):158-176. doi: 10.1161/CIRCRESAHA.123.322875 PMID: 37292677 Free PMC article. Updated. Preprint.
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).
Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Graham C, Semple S, Morris DM, Fraser AR, Pass C, McGowan NWA, Turner ML, Lachlan N, Dillon JF, Campbell JDM, Fallowfield JA, Forbes SJ. Brennan PN, et al. Among authors: pass c. BMJ Open. 2021 Nov 8;11(11):e053190. doi: 10.1136/bmjopen-2021-053190. BMJ Open. 2021. PMID: 34750149 Free PMC article.
Safety profile of autologous macrophage therapy for liver cirrhosis.
Moroni F, Dwyer BJ, Graham C, Pass C, Bailey L, Ritchie L, Mitchell D, Glover A, Laurie A, Doig S, Hargreaves E, Fraser AR, Turner ML, Campbell JDM, McGowan NWA, Barry J, Moore JK, Hayes PC, Leeming DJ, Nielsen MJ, Musa K, Fallowfield JA, Forbes SJ. Moroni F, et al. Among authors: pass c. Nat Med. 2019 Oct;25(10):1560-1565. doi: 10.1038/s41591-019-0599-8. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591593 Clinical Trial.
40 results